PuriCore Announces Final Results

Pennsylvania--(Marketwire - April 28, 2009) -

                        PuriCore plc

       Final Results for the Year Ended 31 December 2008

    Sales Increase 80.9% and Cashflow Significantly Improved


MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 28 April 2009 - PuriCore
(LSE: PURI), the life sciences company focused on developing and
commercialising proprietary, green solutions that safely, effectively
and naturally kill infectious pathogens without causing harm to human
health or the environment, announces its Final Results for the year
ended 31 December 2008 and the availability of its 2008 annual report
on its website. PuriCore also announced today its Interim Management
Statement for Q1 2009 (see separate release).


Financial Highlights
  . Revenues up 80.9% to USD33.7 million (2007: USD18.6 million)
      - Food Safety sales up 147% to USD19.4 million (2007: USD7.9
        million)
      - Endoscopy sales up 34.9% to USD13.8 million (2007: USD10.3
        million)
  . Operational cash outflow halved to USD6.6 million (2007: USD14.1
    million)
  . SG&A expenses down 10% (net of depreciation, amortisation, and
    non-cash share option expense)

Operational Highlights
  . Sterilox Food Safety Systems installed in more than 2,400 retail
    stores (with two of the top-five chains implementing full network
    rollouts)
  . Won Food Safety contracts totaling USD35 million including all
    Safeway's North American stores
  . Sterilox Systems used in a quarter of UK NHS endoscopy departments
  . More than 4,000 wound therapy patients treated: clinicians report
    no adverse side effects
  . New Sterilox Food Safety System Model 2200 launched
  . Completed fundraisings
      - GBP8.4 million in equity
      - USD9.7 million in debt
  . Sterilox Solution found effective against H5N1 avian influenza
  . Sterilox System approved for organic food processing by the Organic
    Materials Review Institute



Greg Bosch, Chief Executive of PuriCore, said:"PuriCore delivered a strong
performance in 2008, resulting in record
revenues in both the US Food Safety and UK Endoscopy core businesses
whilst operating expenses were more than halved. In the current year,
we have continued to see increasing revenues and remain focused on
improving gross margins whilst leveraging our operating expenses. We
believe we are well-positioned to deliver another strong year of
revenue growth and achieve profitability for both our core businesses
during 2009."

Enquiries:

Ben Brewerton           Greg Bosch, CEO
Susan Quigley           Darren Weiss, VP Finance
Financial Dynamics      PuriCore
+44 (0) 20 7831 3113    +1 484 321 2700
Click on, or paste the following link into your web browser, to view
the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/2473R_1-2009-4-27.pdf


                    This information is provided by RNS
          The company news service from the London Stock Exchange

END

Contacts:
RNS Customer Services
0044-207797-4400
Email Contact
http://www.rns.com

MORE ON THIS TOPIC